NO20016370L - Respiratorisk syncytialvirus-replikasjonsinhibitorer - Google Patents

Respiratorisk syncytialvirus-replikasjonsinhibitorer

Info

Publication number
NO20016370L
NO20016370L NO20016370A NO20016370A NO20016370L NO 20016370 L NO20016370 L NO 20016370L NO 20016370 A NO20016370 A NO 20016370A NO 20016370 A NO20016370 A NO 20016370A NO 20016370 L NO20016370 L NO 20016370L
Authority
NO
Norway
Prior art keywords
respiratory syncytial
syncytial virus
virus replication
replication inhibitors
inhibitors
Prior art date
Application number
NO20016370A
Other languages
English (en)
Other versions
NO20016370D0 (no
NO321599B1 (no
Inventor
Frans Eduard Janssens
Jean Fernand Armand Lacrampe
Jerome Emile George Guillemont
Marc Gaston Venet
Koenraad Jozef Lodewij Andries
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20016370D0 publication Critical patent/NO20016370D0/no
Publication of NO20016370L publication Critical patent/NO20016370L/no
Publication of NO321599B1 publication Critical patent/NO321599B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20016370A 1999-06-28 2001-12-27 Respiratorisk syncytialvirusreplikasjonsinhibitorer NO321599B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202089 1999-06-28
PCT/EP2000/005677 WO2001000615A1 (en) 1999-06-28 2000-06-20 Respiratory syncytial virus replication inhibitors

Publications (3)

Publication Number Publication Date
NO20016370D0 NO20016370D0 (no) 2001-12-27
NO20016370L true NO20016370L (no) 2001-12-27
NO321599B1 NO321599B1 (no) 2006-06-06

Family

ID=8240374

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016370A NO321599B1 (no) 1999-06-28 2001-12-27 Respiratorisk syncytialvirusreplikasjonsinhibitorer

Country Status (34)

Country Link
US (2) US7071192B1 (no)
EP (2) EP1196410B1 (no)
JP (1) JP2003503403A (no)
KR (1) KR100731273B1 (no)
CN (1) CN1171887C (no)
AR (1) AR024495A1 (no)
AT (2) ATE356121T1 (no)
AU (1) AU774829B2 (no)
BG (1) BG65373B1 (no)
BR (1) BR0011997A (no)
CA (1) CA2376785A1 (no)
CZ (1) CZ20014573A3 (no)
DE (2) DE60008382T2 (no)
DK (1) DK1196410T3 (no)
EA (1) EA004746B1 (no)
EE (1) EE04592B1 (no)
ES (2) ES2283716T3 (no)
HK (1) HK1045998B (no)
HR (2) HRP20010934A2 (no)
HU (1) HUP0201789A3 (no)
IL (2) IL147328A0 (no)
MX (1) MXPA02000117A (no)
MY (1) MY129810A (no)
NO (1) NO321599B1 (no)
NZ (1) NZ515392A (no)
PL (1) PL200694B1 (no)
PT (1) PT1196410E (no)
SI (1) SI1196410T1 (no)
SK (1) SK18952001A3 (no)
TR (2) TR200500707T2 (no)
TW (1) TWI267513B (no)
UA (1) UA75866C2 (no)
WO (1) WO2001000615A1 (no)
ZA (1) ZA200110473B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495580B1 (en) 1998-01-29 2002-12-17 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
US20040010004A1 (en) 2000-01-17 2004-01-15 Naoki Tsuchiya Benzimidazole derivatives
JP3923255B2 (ja) 1998-07-15 2007-05-30 帝人株式会社 チオベンズイミダゾール誘導体
DE60130865T2 (de) * 2000-01-17 2008-07-17 Teijin Pharma Ltd. Benzimidazol-derivate als menschliche chymase - inhibitoren
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
AU2002239348A1 (en) 2000-12-15 2002-06-24 Glaxo Group Limited Pyrazolopyridine derivatives
DE60112609T2 (de) 2000-12-15 2006-01-19 Glaxo Group Ltd., Greenford Pyrazolopyridine
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
EP1366048B1 (en) 2001-03-08 2004-08-25 SmithKline Beecham Corporation Pyrazolopyridine derivatives
EP1372643A1 (en) 2001-03-30 2004-01-02 Smithkline Beecham Corporation Pyrazolopyridines, process for their preparation and use as therapeutic compounds
EP1377575B1 (en) 2001-04-10 2006-07-05 SmithKline Beecham Corporation Antiviral pyrazolopyridine compounds
JP2004527560A (ja) 2001-04-27 2004-09-09 スミスクライン ビーチャム コーポレーション ピラゾロ［１，５−α］ピリジン誘導体
US7030150B2 (en) 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
CA2451008A1 (en) 2001-06-21 2003-01-03 Smithkline Beecham Corporation Imidazo[1,2-a!pyridine derivatives for the prophylaxis and treatment of herpes viral infections
ES2262893T3 (es) 2001-10-05 2006-12-01 Smithkline Beecham Corporation Derivados de imidazo-piridina para su uso en el tratamiento de infeccion virica por herpes.
US6919331B2 (en) 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
ES2292839T3 (es) 2001-12-11 2008-03-16 Smithkline Beecham Corporation Derivados de pirazolo-piridina como agentes contra el herpes.
US7244847B2 (en) * 2002-02-06 2007-07-17 Isis Pharmaceuticals, Inc. Benzimidazole compounds
CA2495266A1 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
CA2495245A1 (en) 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1546148A1 (en) 2002-10-03 2005-06-29 SmithKline Beecham Corporation Therapeutic compounds based on pyrazolopyridine derivatives
EP1682547B1 (en) * 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
TWI378926B (en) * 2003-12-18 2012-12-11 Tibotec Pharm Ltd Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
CA2548666C (en) * 2003-12-18 2012-08-07 Tibotec Pharmaceuticals Ltd. Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
AR046959A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Morfolinilo que contiene bencimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
AR046971A1 (es) * 2003-12-18 2006-01-04 Tibotec Pharm Ltd Aminobenzoimidazoles y benzoimidazoles como inhibidores de la replicacion del virus sincitial respiratorio
US7355051B2 (en) * 2003-12-18 2008-04-08 Tibotec Pharmaceuticals Piperdine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication
DK1697347T3 (da) * 2003-12-18 2011-06-06 Tibotec Pharm Ltd 5- eller 6-substituerede benzimidazolderivater som inhibitorer af replikation af respiratorisk syncytial-virus
ES2574670T3 (es) * 2005-03-17 2016-06-21 Janssen Sciences Ireland Uc 1,3-Dihidro-bencimidazol-2-ilidenoaminas como inhibidores de replicación del virus sincicial respiratorio
EP1896449B1 (en) * 2005-06-20 2013-11-06 Janssen R&D Ireland Heterocyclylaminoalkyl substituted benzimidazoles
JP5078887B2 (ja) * 2005-06-20 2012-11-21 テイボテク・フアーマシユーチカルズ 呼吸器シンシチウムウイルスに活性をもつ、１−（２−アミノ−３−（置換アルキル）−３ｈ−ベンズイミダゾイルメチル）−３−置換−１，３−ジヒドロ−ベンゾイミダゾル−２−オン
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
WO2010045276A2 (en) * 2008-10-16 2010-04-22 Cara Therapeutics, Inc. Azabenzimidazolones
JP5487692B2 (ja) 2009-04-10 2014-05-07 国立大学法人京都大学 複素環骨格を有する化合物および該化合物を不斉触媒として用いる光学活性化合物の製造方法
US8993604B2 (en) 2009-06-30 2015-03-31 Siga Technologies, Inc. Treatment and prevention of dengue virus infections
BRPI1009034A2 (pt) * 2009-06-30 2019-09-24 Siga Tech Inc composição farmacêutica e método para o tratamento ou profilaxia de uma infecção viral ou doença associada a mesma
KR20140040801A (ko) * 2011-07-15 2014-04-03 시오노기세야쿠 가부시키가이샤 Ａｍｐｋ 활성화 작용을 갖는 아자벤즈이미다졸 유도체
ES2779748T3 (es) * 2012-08-23 2020-08-19 Janssen Biopharma Inc Compuestos para el tratamiento de infecciones víricas por paramixovirus
JP2016079168A (ja) 2014-10-17 2016-05-16 塩野義製薬株式会社 ９員縮合環誘導体

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140119A (en) * 1978-04-03 1983-01-25 Joseph Torremans N-heterocyclyl-4-piperidinamines
US4556660A (en) 1982-07-12 1985-12-03 Janssen Pharmaceutica N.V. N-(Bicyclic heterocyclyl)-4-piperidinamines
US4634704A (en) 1983-10-06 1987-01-06 Janssen Pharmaceutica, N.V. Anti-allergic five membered heterocyclic ring containing N-(bicyclic heterocycyl)-4-piperidinamines
US4695569A (en) 1983-11-30 1987-09-22 Janssen Pharmaceutica N.V. Bicyclic heterocyclyl containing N-(bicyclic heterocyclyl)-4-piperidinamines
DE3484096D1 (de) 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
PH23995A (en) 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
US4588722A (en) 1984-01-09 1986-05-13 Janssen Pharmaceutica N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives
EG17993A (en) 1986-02-03 1991-08-30 Janssen Pharmaceutica Nv Anti-histaminic compositions containing n-heterocyclyl-4-piperidinanines
US4897401A (en) 1987-06-19 1990-01-30 Janssen Pharmaceutical N.V. N-(4-piperidinyl) bicyclic condensed 2-imidazolamine derivatives useful in treating allergic diseases
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines
GB8716313D0 (en) 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines
US5597824A (en) 1987-11-03 1997-01-28 Abbott Laboratories Analogs of oxetanyl purines and pyrimidines
IE904378A1 (en) 1989-12-20 1991-07-03 Abbott Lab Analogs of oxetanyl purines and pyrimidines
KR100190299B1 (ko) 1990-07-19 1999-06-01 디르크 반테 신규한 옥사졸릴 유도체
NZ238863A (en) 1990-07-19 1993-03-26 Janssen Pharmaceutica Nv Substituted thiazolyl and pyridinyl derivatives
US5567824A (en) 1994-05-24 1996-10-22 Merck & Co., Inc. Palladium catalyzed ring closure of triazolyltryptamine
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
PE107598A1 (es) * 1996-09-11 1999-01-29 Ucb Sa Cetirizina util para el tratamiento de enfermedades de tipo virico
AU6031898A (en) * 1997-01-22 1998-08-07 Eli Lilly And Company Anti-viral compounds
EP1001767A4 (en) 1997-06-04 2001-07-04 Lilly Co Eli ANTIVIRAL CONNECTIONS
KR20010032968A (ko) 1998-03-06 2001-04-25 디르크 반테 글리신 수송 저해제
CA2338147A1 (en) 1998-07-20 2000-02-03 Kuo-Long Yu Substituted benzimidazole antiviral agents

Also Published As

Publication number Publication date
JP2003503403A (ja) 2003-01-28
KR100731273B1 (ko) 2007-06-21
ATE259796T1 (de) 2004-03-15
US20060058309A1 (en) 2006-03-16
AU5222200A (en) 2001-01-31
EP1400519B1 (en) 2007-03-07
EA004746B1 (ru) 2004-08-26
NO20016370D0 (no) 2001-12-27
KR20020000815A (ko) 2002-01-05
TR200500707T2 (tr) 2005-04-21
DE60033859T2 (de) 2007-11-08
CA2376785A1 (en) 2001-01-04
DE60008382D1 (en) 2004-03-25
US7071192B1 (en) 2006-07-04
SK18952001A3 (sk) 2002-11-06
WO2001000615A8 (en) 2002-01-10
ES2283716T3 (es) 2007-11-01
CZ20014573A3 (cs) 2002-05-15
HRP20080390A2 (en) 2008-12-31
DE60008382T2 (de) 2004-12-02
EE04592B1 (et) 2006-02-15
HK1045998B (zh) 2005-06-03
PL200694B1 (pl) 2009-01-30
IL147328A0 (en) 2002-08-14
AU774829B2 (en) 2004-07-08
CN1171887C (zh) 2004-10-20
HRP20010934A2 (en) 2003-06-30
SI1196410T1 (en) 2004-08-31
PT1196410E (pt) 2004-07-30
BR0011997A (pt) 2002-03-05
EP1196410B1 (en) 2004-02-18
MXPA02000117A (es) 2002-07-02
AR024495A1 (es) 2002-10-02
HK1045998A1 (en) 2002-12-20
NZ515392A (en) 2004-03-26
NO321599B1 (no) 2006-06-06
BG65373B1 (bg) 2008-04-30
HUP0201789A3 (en) 2003-12-29
TR200103805T2 (tr) 2002-06-21
DE60033859D1 (de) 2007-04-19
BG106288A (en) 2002-10-31
ZA200110473B (en) 2003-03-20
CN1358182A (zh) 2002-07-10
EP1196410A1 (en) 2002-04-17
MY129810A (en) 2007-05-31
ES2215670T3 (es) 2004-10-16
UA75866C2 (en) 2006-06-15
US7407969B2 (en) 2008-08-05
EE200100694A (et) 2003-02-17
HUP0201789A2 (hu) 2002-11-28
EA200200086A1 (ru) 2002-06-27
WO2001000615A1 (en) 2001-01-04
IL147328A (en) 2007-06-03
DK1196410T3 (da) 2004-06-28
TWI267513B (en) 2006-12-01
ATE356121T1 (de) 2007-03-15
EP1400519A1 (en) 2004-03-24
PL352385A1 (en) 2003-08-25

Similar Documents

Publication Publication Date Title
NO20016368D0 (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016369L (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
NO20016370D0 (no) Respiratorisk syncytialvirus-replikasjonsinhibitorer
ATE540013T1 (de) Naphthalinderivate
ZA200110478B (en) Respiratory syncytial virus replication inhibitors.
ES1046532Y (es) Inhalador perfeccionado
FR2816398B3 (fr) Fronde perfectionnee
ES1047576Y (es) Nebulizador perfeccionado.
DE60026702D1 (de) Beatmungssystem
ES1046387Y (es) Rodapie perfeccionado
ES1047372Y (es) Pararrayos perfeccionado
IT1314780B1 (it) Fucile perfezionato
IT1315765B1 (it) Guard-rail perfezionato.
DK1267974T3 (da) Inhalationsapparat